These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33388125)

  • 1. Structure-based glycoconjugate vaccine design: The example of Group B Streptococcus type III capsular polysaccharide.
    Carboni F; Adamo R
    Drug Discov Today Technol; 2020 Dec; 35-36():23-33. PubMed ID: 33388125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate Vaccine.
    Oldrini D; Del Bino L; Arda A; Carboni F; Henriques P; Angiolini F; Quintana JI; Calloni I; Romano MR; Berti F; Jimenez-Barbero J; Margarit I; Adamo R
    Chemistry; 2020 Jun; 26(31):7018-7025. PubMed ID: 32058627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
    Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
    ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A maternal vaccine against group B Streptococcus: past, present, and future.
    Chen VL; Avci FY; Kasper DL
    Vaccine; 2013 Aug; 31 Suppl 4(0 4):D13-9. PubMed ID: 23973342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines.
    Edwards MS; Lane HJ; Hillier SL; Rench MA; Baker CJ
    Vaccine; 2012 Jun; 30(28):4123-6. PubMed ID: 22537994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Immune Responses to Group B Streptococcus Type III Oligosaccharides Containing a Minimal Protective Epitope.
    Carboni F; Angiolini F; Fabbrini M; Brogioni B; Corrado A; Berti F; Adamo R; Margarit I
    J Infect Dis; 2020 Mar; 221(6):943-947. PubMed ID: 31641758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
    Palmeiro JK; De Carvalho NS; Botelho AC; Fracalanzza SE; Madeira HM; Dalla-Costa LM
    Vaccine; 2011 May; 29(21):3729-30. PubMed ID: 21414381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates.
    Campisi E; Rosini R; Romano MR; Balducci E; Pinto V; Brogioni B; De Ricco R; Fabbrini M; Spagnuolo A; Chiarot E; Berti F; Margarit I
    Glycoconj J; 2021 Aug; 38(4):447-457. PubMed ID: 33956253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
    Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
    Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on vaccination against group B streptococcus.
    Heath PT
    Expert Rev Vaccines; 2011 May; 10(5):685-94. PubMed ID: 21604988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
    Palazzi DL; Rench MA; Edwards MS; Baker CJ
    J Infect Dis; 2004 Aug; 190(3):558-64. PubMed ID: 15243932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semisynthetic Glycoconjugate Vaccines To Elicit T Cell-Mediated Immune Responses and Protection against
    Feng S; Xiong C; Wang S; Guo Z; Gu G
    ACS Infect Dis; 2019 Aug; 5(8):1423-1432. PubMed ID: 31126171
    [No Abstract]   [Full Text] [Related]  

  • 13. Surface Structures of Group B
    Paoletti LC; Kasper DL
    Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30873933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of experimental conjugated and combined vaccines against group B streptococci].
    Ditina MA; Meringova LF; Leont'eva GF; Frabovskaia KB; Yang A; Shen Z; Suvorov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):37-41. PubMed ID: 19338234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.
    Guttormsen HK; Baker CJ; Nahm MH; Paoletti LC; Zughaier SM; Edwards MS; Kasper DL
    Infect Immun; 2002 Apr; 70(4):1724-38. PubMed ID: 11895934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
    Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
    J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designer vaccines to prevent infections due to group B Streptococcus.
    Kasper DL
    Proc Assoc Am Physicians; 1995 Oct; 107(3):369-73. PubMed ID: 8608425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling.
    Wang JY; Chang AH; Guttormsen HK; Rosas AL; Kasper DL
    Vaccine; 2003 Mar; 21(11-12):1112-7. PubMed ID: 12559788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of a protective epitope of group B
    Carboni F; Adamo R; Fabbrini M; De Ricco R; Cattaneo V; Brogioni B; Veggi D; Pinto V; Passalacqua I; Oldrini D; Rappuoli R; Malito E; Margarit IYR; Berti F
    Proc Natl Acad Sci U S A; 2017 May; 114(19):5017-5022. PubMed ID: 28439022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.